Pallas Health vs RxActivate: clinician options and pricing clarity

Pallas Health vs RxActivate: Pallas gives specific starting prices and offers both FDA-approved brand-name GLP-1s and compounded semaglutide or tirzepatide with clinician review, while RxActivate requires an eligibility questionnaire and contact information before revealing any price. Early verdict: choose Pallas for transparent starting costs and explicit brand-plus-compounded options; choose RxActivate if you prefer to confirm personalized eligibility before seeing plans.

See Pallas Health plans and starting prices

Pricing and payment transparency

Pallas Health publishes compound plan pricing: compounded semaglutide is $139 for the first month then $597 every 12 weeks (a $199 per month average), and compounded tirzepatide is $179 first month then $897 every 12 weeks (a $299 per month average). Pallas also lists cash-pay monthly prices for specific FDA-approved brand medications such as Wegovy, Ozempic, Zepbound and Mounjaro. RxActivate does not display price, medication fee, membership fee, shipping charge, cancellation term or billing commitment before the contact-information gate. The clear difference: Pallas provides upfront starting prices; RxActivate requires you to complete eligibility details and submit contact information before any cost information appears.

CTA and next steps for price-minded users

Start RxActivate eligibility quiz to see pricing

Medication selection and clinician role

Both providers emphasize clinician review, but they position medication options differently. Pallas Health explicitly offers a choice determined by a US-licensed clinician between FDA-approved brand-name GLP-1s (Wegovy, Ozempic, Zepbound, Mounjaro) and clinician-personalized compounded semaglutide or tirzepatide prepared in the USA when a brand medication is not the right fit. RxActivate describes clinician-matched GLP-1 plans and a state and medical-safety screening, but the specific medication options and whether brand or compounded products will be offered are revealed only after eligibility and contact-information steps. Both note that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.

Intake flow and eligibility gating

RxActivate uses a two-minute eligibility questionnaire that requests goal, height, weight, target weight, timeline, medication history, sex assigned at birth, date of birth, state and safety screening. The flow displayed likely eligibility in a synthetic test but then required name, email and phone before revealing plans or price. Pallas Health performs clinician review and in most states (43 of 50) is asynchronous and does not require a video visit; seven states plus Washington, D.C., require a video visit. RxActivate confirmed serviceability in Alabama in testing. The main distinction is that RxActivate gates price and plan details behind contact submission while Pallas publishes plan types and starting prices up front.

Plan inclusions, shipping and renewals

Pallas includes provider care, ongoing check-ins and messaging inside the plan price and states there is no membership fee. Pallas offers free expedited and discreet shipping and notes compounded plans renew every 12 weeks, so the intro month is a first-month price and plans renew at the stated 12-week rates. RxActivate’s publicly captured details do not disclose shipping, membership or renewal terms before the contact-information gate. For users who need explicit renewal cadence and shipping commitments before signing up, Pallas gives specific renewal pricing for compounded plans while RxActivate requires intake to reveal those terms.

Regulatory notes and limitations

Both providers include regulatory cautions about compounded medications. Pallas explicitly states compounded medications are not FDA-approved and are prepared by US-licensed compounding pharmacies; it also notes Pallas does not manufacture or compound medication and that compounded products may differ in appearance from images on site. RxActivate notes medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable. Both emphasize that treatment is available only when a licensed clinician determines it is medically appropriate.

Review Pallas Health clinician-reviewed options

Which differences matter most

If upfront pricing and a clear listing of both brand and compounded options are priorities, Pallas Health supplies those specifics and includes provider care in the plan price. If you want eligibility pre-checked and prefer to confirm medical matching before viewing any plan, RxActivate enforces that flow by gating pricing and plan details behind an intake and contact step.

Choose Pallas Health to view starting prices now

Conclusion and final recommendation: Pallas Health vs RxActivate

In a direct comparison, Pallas Health stands out for transparent starting prices, explicit brand-name plus compounded medication options, included provider care and clear renewal cadence for compounded plans. RxActivate focuses on clinician matching and requires an eligibility quiz and contact information before revealing pricing or plan terms. Choose based only on the facts each provider publishes.

Choose Pallas Health if you want published starting prices, explicit brand-name and compounded options, included clinician care and free expedited shipping. Choose RxActivate if you prefer a gated eligibility-first flow that reveals personalized plans and pricing only after you complete the questionnaire and provide contact information.

Begin RxActivate eligibility quiz